Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Amblyopia News
September 2024 Ophthalmic News Briefs
Bausch + Lomb is working with Goldman Sachs to explore a sale of the company, the Financial Times reported Sept. 14, with private equity the most likely buyer. The move is being evaluated as a way ...
NovaSight Gains Approval in China for CureSight System for Amblyopia
Israel-based NovaSight reported Sept. 4 that its CureSight eye-tracking system for amblyopia in children had gained approval from Chinese regulators, expanding the device’s availability to the thre...
Syfovre, Acthar Gel Receive J-Codes, While Luminopia Gets A-Code
The Centers for Medicare & Medicaid Services (CMS) issued J-codes in Q2-2023 for Syfovre and Acthar Gel and an A-code for Luminopia’s software for amblyopia treatment. The billing codes take effect...
Syfovre, Acthar Gel Receive J-Codes, While Luminopia Gets A-Code
The Centers for Medicare & Medicaid Services (CMS) issued J-codes in Q2-2023 for Syfovre and Acthar Gel and an A-code for Luminopia’s software for amblyopia treatment. The billing codes will take e...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.